Page last updated: 2024-12-07

monobromobimane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Monobromobimane (MBrBi) is a fluorescent probe used in biochemistry and cell biology to study thiols, particularly cysteine residues in proteins. It reacts selectively with thiols to form a fluorescent adduct. MBrBi is synthesized by reacting bimane with bromine. The resulting fluorescent adduct can be detected using fluorescence microscopy or spectroscopy. MBrBi has been used to study various aspects of thiol biochemistry, including protein folding, redox regulation, and the activity of enzymes that utilize thiols as substrates. Its ability to selectively label thiols makes it a valuable tool for studying the dynamics and function of these important molecules within cells. MBrBi has been used to study the effects of various stimuli on thiol levels, including oxidative stress, heavy metal exposure, and changes in pH. It is a versatile tool for studying a wide range of biological processes involving thiols.'

monobromobimane: fluorescent when reacted with thiol group; RN & N1 from CA Vol 91 Form Index; inhibits platelet calcium-dependent protease activity & the ability of dibucaine-stimulated platelets to support factor X activation; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

monobromobimane : A pyrazolopyrazole that consists of 1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione bearing three methyl substituents at positions 2, 5 and 6 as well as a bromomethyl substituent at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID114810
CHEMBL ID1649730
CHEBI ID62825
SCHEMBL ID152679
MeSH IDM0091410

Synonyms (36)

Synonym
9,methyl)(methyl,methyl)bimane
nsc608544
nsc-608544
monobromobimane
mbbr
bromobimane, >=97%
thiolyte mb
71418-44-5
1h,7h-pyrazolo(1,2-a)pyrazole-1,7-dione, 3-(bromomethyl)-2,5,6-trimethyl-
bromobimane
bromobimane, bioreagent, suitable for fluorescence, >=95% (hpce)
7-(bromomethyl)-1,2,6-trimethylpyrazolo[1,2-a]pyrazole-3,5-dione
chebi:62825 ,
CHEMBL1649730
3-(bromomethyl)-2,5,6-trimethyl-1h,7h-pyrazolo[1,2-a]pyrazole-1,7-dione
bimane monobromide
3-(bromomethyl)-2,5,6-trimethyl-1h,7h-pyrazolo(1,2-a)pyrazole-1,7-dione
v23uk0cyxl ,
unii-v23uk0cyxl
FT-0628974
EPITOPE ID:153547
SCHEMBL152679
DTXSID70221609
monobromo-bimane
AHEWZZJEDQVLOP-UHFFFAOYSA-N
3-(bromomethyl)-2,5,6-trimethylpyrazolo[1,2-a]pyrazole-1,7-dione
B4220
mfcd00036951
AKOS030242700
HY-100041
CS-7526
Q4973726
1h,7h-pyrazolo[1,2-a]pyrazole-1,7-dione,3-(bromomethyl)-2,5,6-trimethyl-
EC-000.2539
D89056
AS-56313

Research Excerpts

Overview

Monobromobimane (mBBr) is a lipophilic reagent that selectively modifies free cysteine residues in proteins. It is a substrate of both mu- and alpha-class rat liver glutathione S-transferases.

ExcerptReferenceRelevance
"Monobromobimane (mBBr), functions as a substrate of porcine glutathione S-transferase pi (GST pi): The enzyme catalyzes the reaction of mBBr with glutathione. "( Monobromobimane occupies a distinct xenobiotic substrate site in glutathione S-transferase pi.
Colman, RF; Ralat, LA, 2003
)
3.2
"Monobromobimane (MBB) is a lipophilic reagent that selectively modifies free cysteine residues in proteins. "( Combining fluorescence detection and mass spectrometric analysis for comprehensive and quantitative analysis of redox-sensitive cysteines in native membrane proteins.
Borchers, CH; Dokholyan, NV; Elms, P; Meissner, G; Pasek, D; Petrotchenko, EV, 2006
)
1.78
"Monobromobimane (mBBr) is a substrate of both mu- and alpha-class rat liver glutathione S-transferases, with Km values of 0.63 microM and 4.9 microM for the mu-class isozymes 3-3 and 4-4, respectively, and 26 microM for the alpha-class isozymes 1-1 and 2-2. "( Probing the active site of alpha-class rat liver glutathione S-transferases using affinity labeling by monobromobimane.
Borleske, BL; Colman, RF; Hu, L, 1997
)
1.95

Effects

ExcerptReferenceRelevance
"Monobromobimane has the advantage that it is highly reactive towards thiols, but its hydrolysis products are also fluorogenic, thus necessitating complex chromatography to obtain satisfactory separation between the compounds of interest and interferents."( Assay methods for the measurement of total homocyst(e)ine in plasma.
Ubbink, JB, 2000
)
1.03

Actions

ExcerptReferenceRelevance
"Monobromobimane does not inhibit the phosphate carrier, nor does it interfere with Ca2+ transport, energy coupling or ATP production and transport."( Selective inhibition of the mitochondrial permeability transition pore at the oxidation-reduction sensitive dithiol by monobromobimane.
Bernardi, P; Chernyak, BV; Costantini, P; Petronilli, V, 1995
)
1.22

Pharmacokinetics

ExcerptReferenceRelevance
" In pharmacokinetic studies, male rats were exposed either to intravenous infusions of sodium sulphide or to H(2)S gas inhalation, and levels of available blood sulphide were measured."( A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood.
Bengtsson, A; Deckwerth, TL; Dumpit, R; Hill, P; Insko, MA; Langston, W; Leviten, D; Szabo, C; Toombs, CF; VandenEkart, E; Wintner, EA, 2010
)
1.08

Bioavailability

ExcerptReferenceRelevance
"Accurate measurement of hydrogen sulfide bioavailability remains a technical challenge due to numerous issues involving sample processing, detection methods used, and actual biochemical products measured."( Hydrogen sulfide measurement using sulfide dibimane: critical evaluation with electrospray ion trap mass spectrometry.
Chakraborty, S; Dugas, TR; Kevil, CG; Shen, X, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organobromine compoundA compound containing at least one carbon-bromine bond.
pyrazolopyrazoleAny organic heterobicyclic compound class containing two ortho-fused pyrazole rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
mycothiol-mediated detoxification110

Bioassays (2)

Assay IDTitleYearJournalArticle
AID564978Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring inactivated p55 gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID564959Antimicrobial activity against Mycobacterium bovis BCG P55 by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (193)

TimeframeStudies, This Drug (%)All Drugs %
pre-199037 (19.17)18.7374
1990's60 (31.09)18.2507
2000's51 (26.42)29.6817
2010's32 (16.58)24.3611
2020's13 (6.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.10 (24.57)
Research Supply Index5.30 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index42.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.50%)5.53%
Reviews2 (1.01%)6.00%
Case Studies1 (0.50%)4.05%
Observational0 (0.00%)0.25%
Other195 (97.99%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]